Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome.
Hrustincova A, Krejcik Z, Kundrat D, Szikszai K, Belickova M, Pecherkova P, Klema J, Vesela J, Hruba M, Cermak J, Hrdinova T, Krijt M, Valka J, Jonasova A, Merkerova MD. Hrustincova A, et al. Among authors: pecherkova p. Cells. 2020 Mar 26;9(4):794. doi: 10.3390/cells9040794. Cells. 2020. PMID: 32224889 Free PMC article.
LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome.
Szikszai K, Krejcik Z, Klema J, Loudova N, Hrustincova A, Belickova M, Hruba M, Vesela J, Stranecky V, Kundrat D, Pecherkova P, Cermak J, Jonasova A, Dostalova Merkerova M. Szikszai K, et al. Among authors: pecherkova p. Cancers (Basel). 2020 Sep 23;12(10):2726. doi: 10.3390/cancers12102726. Cancers (Basel). 2020. PMID: 32977510 Free PMC article.
Linking aberrant glycosylation of plasma glycoproteins with progression of myelodysplastic syndromes: a study based on plasmonic biosensor and lectin array.
Chrastinová L, Pastva O, Bocková M, Kovářová H, Ceznerová E, Kotlín R, Pecherková P, Štikarová J, Hlaváčková A, Havlíček M, Válka J, Homola J, Suttnar J. Chrastinová L, et al. Among authors: pecherkova p. Sci Rep. 2023 Aug 7;13(1):12816. doi: 10.1038/s41598-023-39927-4. Sci Rep. 2023. PMID: 37550349 Free PMC article.
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.
Jaruskova M, Curik N, Hercog R, Polivkova V, Motlova E, Benes V, Klamova H, Pecherkova P, Belohlavkova P, Vrbacky F, Machova Polakova K. Jaruskova M, et al. Among authors: pecherkova p. J Exp Clin Cancer Res. 2017 Apr 18;36(1):55. doi: 10.1186/s13046-017-0523-3. J Exp Clin Cancer Res. 2017. PMID: 28420426 Free PMC article.
BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.
Srutova K, Curik N, Burda P, Savvulidi F, Silvestri G, Trotta R, Klamova H, Pecherkova P, Sovova Z, Koblihova J, Stopka T, Perrotti D, Polakova KM. Srutova K, et al. Among authors: pecherkova p. Haematologica. 2018 Dec;103(12):2016-2025. doi: 10.3324/haematol.2018.193086. Epub 2018 Jul 26. Haematologica. 2018. PMID: 30049824 Free PMC article.
Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant.
Šálek C, Folber F, Froňková E, Pecherková P, Jelínková H, Hrabovský Š, Horáček JM, Cetkovský P, Mayer J, Trka J, Doubek M; Czech Leukemia Study Group - for Life (CELL). Šálek C, et al. Among authors: pecherkova p. Br J Haematol. 2022 Feb;196(3):706-710. doi: 10.1111/bjh.17966. Epub 2021 Nov 23. Br J Haematol. 2022. PMID: 34816424
18 results